Tenon Medical

TNON · NASDAQ

$2.51+$0.06 (+2.45%)TodayMarket closed ·
Prev close $2.45

About TNON

Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 26 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.

Employees
26
Headquarters
Los Gatos, California
Listed
Apr 27, 2022
Sector
Health Care
Industry
Health Care Equipment & Supplies

TNON key statistics

Market cap
6.75M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.37M
Volume
84.00K
Open price
$2.45
High today
$2.54
Low today
$2.42
52 Week high
$50.40
52 Week low
$2.40

Tenon Medical (TNON) at a glance

Tenon Medical (TNON) last traded at $2.51, with a market cap of 6.75M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.42 and $2.54. The current price is 3.7% above the day's low and 1.2% below its high.

Volume so far is 84.00K shares, below the average of 3.37M shares a day.

Over the past year Tenon Medical has ranged from $2.40 to $50.40, and now sits 0% of the way up that range.

Tenon Medical met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$12.35 per share against an estimate of -$8.57.

TNON earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 10.8% on average.

  1. Q3 FY24: reported -$127.05 per share against an estimate of -$151.19
  2. Q4 FY24: reported -$88.90 per share against an estimate of -$90.68
  3. Q1 FY25: reported -$35.35 per share against an estimate of -$39.63
  4. Q2 FY25: reported -$12.60 per share against an estimate of -$16.78
  5. Q3 FY25: reported -$14.00 per share against an estimate of -$13.21
  6. Q4 FY25: reported -$13.30 per share against an estimate of -$12.85
  7. Q1 FY26: reported -$10.85 per share against an estimate of -$10.89
  8. Q2 FY26: reported -$12.35 per share against an estimate of -$8.57

TNON news

  • Press releasePRNewswire

    WallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338

  • Press releasePRNewswire

    WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338

  • Avi Kapoor

    Dow Jumps Over 1%; US Inflation Holds at 3.4% In August

  • Henry Khederian

    Tenon Medical Stock Extends Multi-Day Rally: What's Happening?

  • Press releaseGlobe Newswire

    Big Pharma Setbacks Create a New Wave of Rebound Plays

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • Avi Kapoor

    Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results

  • Henry Khederian

    Tenon Medical Stock Surges Thursday: What's Driving the Action?

Similar companies

Companies in the same industry as Tenon Medical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.